ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

NCI TO Issue RFA For Gene Therapy Studies; $20 Mil. Se-Aside Ok’d

January 10, 1992

Funding Opportunities

September 13, 2002

Radiation To Stem Cell Niche Improved PFS In Glioblastoma

August 27, 2010

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Small Study: Radiation, Chemo May Better Control Anal Cancer

November 26, 2010

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000